Menarini Diagnostics acquires EOS Preanalytics and Point Of Care company assets

FLORENCE, January 15th, 2021 - Menarini Diagnostics, a company of the Menarini Group

A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON^® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.

September 3rd, 2020 – Firenze, Italy and Bad Homburg, Germany

ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR^® POC instrument.

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

Menarini Diagnostics announces Technology Transfer Agreement to develop its own COVID 19 RT PCR assay